HuGE Literature Finder
Records 1-27
|
Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread.
Gynecologic oncology reports 2021 May 36 100720. Sullivan Stephanie A, Hawkins Gabriel, Zhao Xiobai, Jo Heejoon, Hayes Neil, Deng Xiaoyan, Bandyopadhyay Dipankar, Bae-Jump Victoria L, Rossi Emma |
|
PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
Gynecologic oncology 2021 Apr . Gonzalez-Bosquet Jesus, Bakkum-Gamez Jamie N, Weaver Amy L, McGree Michaela E, Dowdy Sean C, Famuyide Abimbola O, Kipp Benjamin R, Halling Kevin C, Couch Fergus J, Podratz Karl |
|
Endometrial Cancer Risk in Women with Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
Journal of the National Cancer Institute 2021 Mar . de Jonge Marthe M, de Kroon Cornelis D, Jenner Denise J, Oosting Jan, de Hullu Joanne A, Mourits Marian J E, Garcia Encarna B Gómez, Ausems Margreet G E M, Collée J Margriet, van Engelen Klaartje, van de Beek Irma, , Smit Vincent T H B M, Rookus Matti A, de Bock Geertruida H, van Leeuwen Flora E, Bosse Tjalling, Dekkers Olaf M, van Asperen Christi |
|
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.
Journal of translational medicine 2021 Feb 19 (1): 51. Feng Weiwei, Jia Nan, Jiao Haining, Chen Jun, Chen Yan, Zhang Yueru, Zhu Menghan, Zhu Chongying, Shen Lifei, Long Wenqi |
|
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
The American journal of surgical pathology 2020 May . Leskela Susanna, Romero Ignacio, Rosa-Rosa Juan M, Caniego-Casas Tamara, Cristobal Eva, Pérez-Mies Belén, Gutierrez-Pecharroman Ana, Santón Almudena, Ojeda Belén, López-Reig Raquel, Palacios-Berraquero María L, Andrada Encarna, Montes Santiago, Pastor Francisco, Gomez Maria C, López-Guerrero José A, Poveda Andrés, Palacios Jo |
|
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Pathology oncology research : POR 2020 May . Travaglino Antonio, Raffone Antonio, Gencarelli Annarita, Mollo Antonio, Guida Maurizio, Insabato Luigi, Santoro Angela, Zannoni Gian Franco, Zullo Fulv |
|
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
International journal of cancer 2020 Feb . Reijnen C, Küsters-Vandevelde H V N, Ligtenberg M J L, Bulten J, Oosterwegel M, Snijders M P L M, Sweegers S, de Hullu J A, Vos M C, van der Wurff A A M, van Altena A M, Eijkelenboom A, Pijnenborg J M |
|
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
Reproductive sciences (Thousand Oaks, Calif.) 2020 Jan . Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Vergoni Federica, Amunni Gianni, Fambrini Massimiliano, Petraglia Felice, Noci Ivo, Pillozzi Sere |
|
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy.
Gynecologic oncology reports 2019 Nov 30 100521. Octeau David, Abitbol Jeremie, Amajoud Zainab, Laskov Ido, Ferenczy Alex, Pelmus Manuela, Eisenberg Neta, Kessous Roy, Matanes Emad, Lau Susie, Yasmeen Amber, Lopez-Ozuna Vanessa, Salvador Shannon, Gotlieb Walter H, Kogan Lir |
|
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Gynecologic oncology 2019 Jul . Cybulska Paulina, Paula Arnaud Da Cruz, Tseng Jill, Leitao Mario M, Bashashati Ali, Huntsman David G, Nazeran Tayyebeh M, Aghajanian Carol, Abu-Rustum Nadeem R, DeLair Deborah F, Shah Sohrab P, Weigelt Brit |
|
Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Cancer science 2018 Oct . Matsuura Motoki, Yamaguchi Kiyoshi, Tamate Masato, Satohisa Seiro, Teramoto Mizue, Iwasaki Masahiro, Sugita Shintaro, Hasegawa Tadashi, Koubo Rika, Takane Kiyoko, Ikenoue Tsuneo, Furukawa Yoichi, Saito Tsuyos |
|
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors.
Gynecologic oncology reports 2018 May 24 43-47. Kogan Liron, Octeau David, Amajoud Zainab, Abitbol Jeremie, Laskov Ido, Ferenczy Alex, Pelmus Manuela, Eisenberg Neta, Kessous Roy, Lau Susie, Yasmeen Amber, Gotlieb Walter H, Salvador Shann |
|
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Oncotarget 2018 Mar 9 (24): 17093-17103. Guttery David S, Blighe Kevin, Polymeros Konstantinos, Symonds R Paul, Macip Salvador, Moss Esther |
|
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Cancer 2017 Sep 123 (17): 3261-3268. Le Gallo Matthieu, Rudd Meghan L, Urick Mary Ellen, Hansen Nancy F, Zhang Suiyuan, , Lozy Fred, Sgroi Dennis C, Vidal Bel August, Matias-Guiu Xavier, Broaddus Russell R, Lu Karen H, Levine Douglas A, Mutch David G, Goodfellow Paul J, Salvesen Helga B, Mullikin James C, Bell Daphne |
|
Impact of age at diagnosis on racial disparities in endometrial cancer patients.
Gynecologic oncology 2017 Aug . Tarney Christopher M, Tian Chunqiao, Wang Guisong, Dubil Elizabeth A, Bateman Nicholas W, Chan John K, Elshaikh Mohamed A, Cote Michele L, Schildkraut Joellen M, Shriver Craig D, Conrads Thomas P, Hamilton Chad A, Maxwell G Larry, Darcy Kathleen |
|
Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Experimental and molecular pathology 2015 Nov . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
|
TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.
Medical oncology (Northwood, London, England) 2014 Nov 31 (11): 286. Zaj?c Agnieszka, Smolarz Beata, Stachowiak Grzegorz, Wilczy?ski Jacek |
|
MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.
British journal of cancer 2014 Jun 110 (12): 2874-80. Nagy E, Gajjar K B, Patel I I, Taylor S, Martin-Hirsch P L, Stringfellow H F, Martin F L, Phillips D |
|
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
Oncology reports 2013 Jul 30 (1): 25-34. Yoneda Tomoko, Kuboyama Ayumi, Kato Kiyoko, Ohgami Tatsuhiro, Okamoto Kanako, Saito Toshiaki, Wake Nor |
|
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Gynecologic oncology 2013 Feb 128 (2): 327-34. Garcia-Dios Diego A, Lambrechts Diether, Coenegrachts Lieve, Vandenput Ingrid, Capoen An, Webb Penelope M, Ferguson Kaltin, , Akslen Lars A, Claes Bart, Vergote Ignace, Moerman Philippe, Van Robays Johan, Marcickiewicz Janusz, Salvesen Helga B, Spurdle Amanda B, Amant Frédér |
|
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2013 Jan . Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD |
|
Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.
Post?py higieny i medycyny do?wiadczalnej (Online) 2013 67 (0): 1312-8. Zaj?c Agnieszka, Stachowiak Grzegorz, Smolarz Beata, Wilczy?ski Jacek |
|
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/ß-catenin and P53 pathway activation.
Gynecologic oncology 2012 Sep 126 (3): 466-73. Nout Remi A, Bosse Tjalling, Creutzberg Carien L, Jürgenliemk-Schulz Ina M, Jobsen Jan J, Lutgens Ludy C H W, van der Steen-Banasik Elzbieta M, van Eijk Ronald, Ter Haar Natalja T, Smit Vincent T H B |
|
TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Medical oncology (Northwood, London, England) 2011 Dec 28 (4): 1129-35. Jiang De-Ke, Yao Lei, Ren Wei-Hua, Wang Wen-Zhang, Peng Bo, Yu Lo |
|
Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Cancer genetics and cytogenetics 2010 Jan 196 (2): 167-70. Ghasemi Nasrin, Karimi-Zarchi Mojgan, Mortazavi-Zadeh Mohammad Reza, Atash-Afza A |
|
Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
Gynecologic oncology 2009 Apr 113 (1): 109-14. Ashton Katie A, Proietto Anthony, Otton Geoffrey, Symonds Ian, McEvoy Mark, Attia John, Gilbert Michael, Hamann Ute, Scott Rodney |
|
Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset.
In vivo (Athens, Greece) 0 33 (3): 917-924. Wujcicka Wioletta, Zajac Agnieszka, Stachowiak Grzego |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 16, 2021
- Content source: